Korro Bio, Inc. (KRRO) - Form 8-K Summary
Business Context and Reporting Period
Korro Bio, Inc., a Delaware corporation, filed this Current Report on Form 8-K on March 12, 2026. The filing serves to announce the company's financial results for the fiscal year ended December 31, 2025. The report is signed by Ram Aiyar, who serves as President, Chief Executive Officer, and Interim Chief Financial Officer.
Financial Metrics
The provided filing text does not contain specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document acts as a cover report referencing a press release (Exhibit 99.1) for the detailed financial data.
Material Changes
No specific material changes or comparative financial data versus prior periods are detailed within the text of this Form 8-K. The filing indicates that the full details of the year-end results are contained in the attached press release.
Guidance, Outlook, and Risks
The filing text does not provide specific guidance, outlook, management commentary, or risk factors. It explicitly states that the information in Item 2.02 and Exhibit 99.1 is not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Facts for Investor Verification
- Verify the full text of the press release (Exhibit 99.1) for actual financial figures for the year ended December 31, 2025.
- Note that Ram Aiyar is serving as the Interim Chief Financial Officer.
- Confirm that the financial data in this 8-K is not legally "filed" under Section 18 of the Exchange Act, limiting its liability status compared to standard 10-K filings.
- Check the Nasdaq Capital Market listing status for the common stock (KRRO).